Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2020-02-24 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Director's Dealing 2020
Director's Dealing Classification · 99% confidence The document title explicitly states 'Trading in Coloplast shares by board members, executives or associated persons'. This directly corresponds to the definition of Director's Dealing (insider trades). Although the text is very short and points to an attachment ('Please see enclosed pdf.'), the specific subject matter (director trading) overrides the general 'Report Publication Announcement' rule, as 'Director's Dealing' is a specific required disclosure category. The code for Director's Dealing is DIRS.
2020-02-24 English
Director's Dealing 2020
Director's Dealing Classification · 100% confidence The document is a formal notification dated February 24, 2020, titled in Danish: "Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer" (Notification of transactions in Coloplast shares and related securities by persons discharging managerial responsibilities and persons closely associated with them). This content explicitly details transactions (option exercise and sales) conducted by a director ('Bestyrelsesformand' - Chairman of the Board), Lars Rasmussen. This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided schema. The relevant code is DIRS.
2020-02-24 Portuguese
Coloplast A/S - Announcement no. 2/2020 - Share Buyback Programme
Transaction in Own Shares Classification · 98% confidence The document is a corporate announcement from Coloplast A/S regarding the initiation of a share buyback program (Aktietilbagekøbsprogram). It details the terms, duration, and regulatory framework (MAR/Safe Harbour) for the repurchase of its own shares. While it mentions a 'Vedhæftet fil' (attached file) at the end, the document itself provides the full context and details of the transaction program, making it a primary announcement of a share repurchase activity rather than just a notification of a report. Therefore, it is classified as a Transaction in Own Shares (POS).
2020-02-21 English
Coloplast A/S - Announcement no. 2/2020 - Share Buyback Programme
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Coloplast A/S regarding the initiation of a share buyback programme. It details the total value (DKK 500 million), the duration, the regulatory framework (MAR/Safe Harbour), and the appointment of a bank to manage the transactions. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2020-02-21 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document is titled 'Coloplast A/S - Announcement no. 2/2020 - Share Buyback Programme' and explicitly details the initiation of a DKK 500 million share buyback programme, including start/end dates, regulatory compliance (MAR, Safe Harbour Regulations), and the appointment of a manager (Danske Bank). This directly relates to the company repurchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). Although it is an announcement, the core content is the transaction details, not just a notice that a report is attached, making POS a more specific fit than RPA or RNS.
2020-02-21 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document is titled "Selskabsmeddelelse nr. 02/2020" (Company Announcement no. 02/2020) and its main subject is the initiation of a share buyback program ("Coloplast iværksætter aktietilbagekøbsprogrammet på 500 millioner kroner"). This action—the company purchasing its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document details the structure, duration, and manager of the buyback, which is a specific corporate action. Therefore, the appropriate classification is POS (Transaction in Own Shares). The document length is relatively short (4719 chars), but it is a direct announcement of the action, not an announcement *about* a report, so RPA/RNS is less specific than POS.
2020-02-21 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.